Skip to main content
ADCT
NYSE Life Sciences

ADC Therapeutics Q2 Loss Narrows to $16.6M, Beats Estimates; Cuts 17% Workforce

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.25
Mkt Cap
$156.445M
52W Low
$0.78
52W High
$4.98
52W Position info
60% above low
Off High info
75% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ADCT sits 60% above its 52-week low of $0.78 on light trading volume (0.3× avg).

Summary

ADC Therapeutics reported Q2 net loss of $16.57M, beating consensus of $33.96M, with net product revenue up slightly year-over-year on higher pricing. The company also cut 17% of its workforce to save $10M annually, a move previously announced in June. Management now expects growth starting in 2027 and is assessing the regulatory path for ZYNLONTA after FDA feedback on the LOTIS-5 trial, with an update on strategy and timing expected in the near future. The stock trades at $1.25 with a median analyst price target of $2.50.

At the time of this announcement, ADCT was trading at $1.25 on NYSE in the Life Sciences sector, with a market capitalization of approximately $156.4M. The 52-week trading range was $0.78 to $4.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ADCT - Latest Insights

ADCT
Nov 09, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.75
Real-time Price: $1.34 info
Change: -$0.411 (-24%) info
Market Cap: $187.08M info
ADCT
Nov 09, 2026, 7:30 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.34 info
Change: -$0.245 (-16%) info
Market Cap: $187.08M info
ADCT
Nov 04, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $1.34 info
Change: -$0.385 (-22%) info
Market Cap: $187.08M info
ADCT
Nov 03, 2026, 5:02 PM EST
Filing Type: S-4
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.34 info
Change: -$0.215 (-14%) info
Market Cap: $187.08M info
ADCT
Oct 13, 2026, 6:26 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.82
Real-time Price: $1.34 info
Change: -$0.485 (-27%) info
Market Cap: $187.08M info